Dutch Drugmaker Prosensa Jumps 54 Percent in US Stock Market Debut

Dutch drugmaker Prosensa jumps 54 percent in US stock market debut

Filed under: drug rehab treatment options

(Reuters) – Dutch drugmaker Prosensa Holding received a buoyant welcome in its market debut on the Nasdaq, a day after U.S. health regulators granted a "breakthrough status" to its drug to treat a rare disease. Prosensa's shares opened $ 7 above its …
Read more on IT Business Net

Dutch drugmaker Prosensa jumps 54 pct in US stock market debut

Filed under: drug rehab treatment options

June 28 (Reuters) – Dutch drugmaker Prosensa Holding received a buoyant welcome in its market debut on the Nasdaq, a day after U.S. health regulators granted a "breakthrough status" to its drug to treat a rare disease. Prosensa's shares opened $ 7 above …
Read more on Reuters

FDA approves non-hormonal hot flash drug

Filed under: drug rehab treatment options

The U.S. Food and Drug Administration today approved the first non-hormonal medicine to treat hot flashes associated with menopause. The drug, Brisdelle, contains the selective serotonin reuptake inhibitor paroxetine mesylate. Other FDA-approved …
Read more on The Tennessean

FDA Approves First Non-hormonal Treatment For Menopause Related Hot Flashes

Filed under: drug rehab treatment options

Specialty pharmaceutical company Noven Pharmaceuticals, Inc. announced Friday that the U.S. Food and Drug Administration has approved its Brisdelle (paroxetine) capsules as treatment for moderate to severe hot flashes (vasomotor symptoms) … with the …
Read more on RTT News